NCT00108498View on ClinicalTrials.gov

New Pharmacological Treatment for Obstructive Sleep Apnea

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 2003

Study Completion Date

March 31, 2007

Conditions

Obstructive Sleep Apnea

Interventions

DRUG

mirtazapine

Trial Locations (1)

32608

Malcom Randall VAMC, Gainesville

All Listed Sponsors

lead

US Department of Veterans Affairs

FED

NCT00108498 - New Pharmacological Treatment for Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter